Lidocaine Infusion in Hystroscopy

Phase 2CompletedNCT03825016

Ain Shams University44 enrolled

Overview

Lidocaine infusion in hystroscopic media versus oral diclofenac

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

QUADRUPLE

Enrollment

Conditions

Pain

Interventions

Lidocaine HydrochlorideDRUG

Lidocaine infusion on hystroscopic media during office hystroscopy

Diclofenac SodiumDRUG

Oral Diclofenac Sodium

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 35 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Age 18-35 years * BMI 18.5-30 kg/m2 * Diagnostic hystroscope Exclusion Criteria: * Previous cervical surgery * Cervical stenosis * PID * allergy to NSAID * Gastritis or peptic ulcer

Locations (1)

Ain Shams University Maternity Hospital

Cairo, Egypt

Outcomes

Primary Outcomes

Degree of pain "measured by visual analogue scale"

measured by visual analogue scale

Time frame: 1 hour

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.